Vanda Pharmaceuticals
VNDA
#7253
Rank
S$0.61 B
Marketcap
S$10.35
Share price
0.25%
Change (1 day)
77.64%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are S$0.21 Billion. In 2024 the company made an earning of -S$51.51 Million a decrease over its 2023 earnings that were of -S$17.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion207.5%
2024 -S$51.51 Million191.43%
2023 -S$17.68 Million-320.45%
2022 S$8.01 M-84.99%
2021 S$53.4 M54.8%
2020 S$34.5 M19.42%
2019 S$28.89 M4.93%
2018 S$27.53 M-228.6%
2017 -S$21.42 Million-8.98%
2016 -S$23.53 Million-53.79%
2015 -S$50.91 Million-30.18%
2014 -S$72.91 Million173.08%
2013 -S$26.7 Million-25.33%
2012 -S$35.76 Million163.61%
2011 -S$13.57 Million-221.15%
2010 S$11.19 M-124.53%
2009 -S$45.65 Million-29.44%
2008 -S$64.69 Million-36.2%
2007 -S$0.11 Billion21.81%
2006 -S$83.24 Million170.55%
2005 -S$30.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.03 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.71 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.01 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.50 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.24 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.17 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-S$3.56 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA